Longmont, CO, United States of America

Peter J Stengel

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 5 CIPO patents and 2 EPO patents. Top assignee: Peloton Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter J Stengel. Retrieved from https://idiyas.com/inventor/peter-j-stengel-yy4pirx4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter J. Stengel

Introduction

Peter J. Stengel is a notable inventor based in Longmont, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dispersions and pharmaceutical compositions. His work focuses on innovative methods for treating HIF-2α-mediated diseases and conditions.

Latest Patents

Peter J. Stengel holds a patent for "Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof." This patent includes solid dispersions that comprise a HIF-2α inhibitor, pharmaceutical compositions that utilize these solid dispersions, and methods for treating related diseases.

Career Highlights

Throughout his career, Stengel has worked with prominent companies in the pharmaceutical industry. He has been associated with Peloton Therapeutics, Inc. and F. Hoffmann-La Roche AG, where he has contributed to various innovative projects and research initiatives.

Collaborations

One of his notable coworkers is Christopher Lindemann, with whom he has collaborated on various projects in the pharmaceutical sector.

Conclusion

Peter J. Stengel's contributions to pharmaceutical innovations highlight his expertise and dedication to improving treatment methods for complex diseases. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…